# MEDROXYPROGESTERONE ACETATE
> **ANDA215397** · Abbreviated New Drug Application (Generic) · Sponsor: AMNEAL · Approved 2023-06-07
## Drug
- **FDA Application Number:** ANDA215397
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** MEDROXYPROGESTERONE ACETATE
- **Generic name:** MEDROXYPROGESTERONE ACETATE
- **Active ingredients:** MEDROXYPROGESTERONE ACETATE
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** AMNEAL
- **Manufacturer:** Amneal Pharmaceuticals LLC
- **First approval:** 2023-06-07
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215397)
---
*MORVS · CC0 1.0*